Meeder Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53M Buy
15,718
+1,170
+8% +$417K 0.23% 66
2025
Q4
$4.76M Buy
14,548
+583
+4% +$185K 0.2% 73
2025
Q3
$3.94M Buy
13,965
+157
+1% +$45.5K 0.18% 82
2025
Q2
$3.86M Sell
13,808
-332
-2% -$94.1K 0.2% 76
2025
Q1
$4.41M Buy
14,140
+1,472
+12% +$435K 0.26% 57
2024
Q4
$3.3M Sell
12,668
-88
-0.7% -$26.1K 0.21% 76
2024
Q3
$4.11M Sell
12,756
-166
-1% -$54.3K 0.27% 58
2024
Q2
$4.04M Buy
12,922
+3,053
+31% +$897K 0.29% 54
2024
Q1
$2.81M Buy
9,869
+366
+4% +$107K 0.29% 60
2023
Q4
$2.74M Buy
9,503
+459
+5% +$125K 0.31% 52
2023
Q3
$2.43M Sell
9,044
-1,183
-12% -$295K 0.31% 51
2023
Q2
$2.27M Buy
10,227
+1,752
+21% +$407K 0.24% 67
2023
Q1
$2.05M Sell
8,475
-926
-10% -$227K 0.24% 78
2022
Q4
$2.47M Buy
+9,401
New +$2.52M 0.31% 56

Other funds holding AMGN

Meeder Advisory Services's AMGN Position: Q1 2026 in Review

Meeder Advisory Services increased its Amgen (AMGN) stake by 8% in Q1 2026, buying an estimated $417K and bringing the position to 15,718 shares worth $5.53M. The position accounts for 0.23% of the portfolio, ranked #66.

Meeder Advisory Services first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Meeder Advisory Services held 15,718 shares of Amgen worth $5.53M as of Q1 2026.
  • Meeder Advisory Services bought 1,170 Amgen shares in Q1 2026, an estimated $417K.
  • Amgen made up 0.23% of Meeder Advisory Services's portfolio in Q1 2026, its #66 holding.
  • Meeder Advisory Services first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.